AvidBiotics Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AvidBiotics Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10893
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥33,750見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥67,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥101,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AvidBiotics Corp (AvidBiotics) is a pharmaceutical company that develops non-antibody therapeutic proteins targeting cancer cells, virus-infected cells and pathogenic bacteria. The company develops a portfolio of therapeutic protein candidates and protein engineering platforms which include avidocin proteins, mica-body proteins and purocin proteins. Its avidocin proteins are used in the treatment of antibiotic-resistant bacterial infections and microbiota management diseases. AvidBiotics’ mica-body proteins are used in immune-oncology applications and treatment of viral infections. The company’s therapeutic proteins are designed to destroy target cells with surgical and laser precision. AvidBiotics is headquartered in South San Francisco, California, the US.

AvidBiotics Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AvidBiotics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AvidBiotics Corp, Medical Devices Deals, 2012 to YTD 2018 9
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
AvidBiotics Raises USD0.9 Million in Venture Financing 11
AvidBiotics Raises Additional US$0.25 Million In Venture Financing 12
AvidBiotics Raises USD1.8 Million in Venture Financing 13
Partnerships 14
AvidBiotics Enters Into Research Agreement With Full Spectrum Genetics 14
Licensing Agreements 15
AvidBiotics Enters Into Co-Development Agreement With DuPont Nutrition To Develop Antibacterial Technology For Food Safety 15
AvidBiotics Corp – Key Competitors 16
AvidBiotics Corp – Key Employees 17
AvidBiotics Corp – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Strategy And Business Planning 19
Nov 01, 2017: AvidBiotics Splits into Two Biotechnology Companies Each Developing its Distinct Technology Platform 19
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
AvidBiotics Corp, Pharmaceuticals & Healthcare, Key Facts 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AvidBiotics Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AvidBiotics Corp, Deals By Therapy Area, 2012 to YTD 2018 8
AvidBiotics Corp, Medical Devices Deals, 2012 to YTD 2018 9
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AvidBiotics Raises USD0.9 Million in Venture Financing 11
AvidBiotics Raises Additional US$0.25 Million In Venture Financing 12
AvidBiotics Raises USD1.8 Million in Venture Financing 13
AvidBiotics Enters Into Research Agreement With Full Spectrum Genetics 14
AvidBiotics Enters Into Co-Development Agreement With DuPont Nutrition To Develop Antibacterial Technology For Food Safety 15
AvidBiotics Corp, Key Competitors 16
AvidBiotics Corp, Key Employees 17

List of Figures
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AvidBiotics Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AvidBiotics Corp, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[AvidBiotics Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Bristol-Myers Squibb Co (BMY):企業の財務・戦略的SWOT分析
    Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Radiomedix Inc-製薬・医療分野:企業M&A・提携分析
    Summary Radiomedix Inc (Radiomedix) is a biotechnology company that provides therapies. The company provides radiopharmaceuticals for diagnosis, monitoring and therapy of cancer. Its products include smartmedix system and glucomedix. Radiomedix’s services include CGMP drug manufacturing suite and mi …
  • KCC Corp (002380):企業の財務・戦略的SWOT分析
    KCC Corp (002380) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Meridian Energy Ltd (MEL):電力:M&Aディール及び事業提携情報
    Summary Meridian Energy Ltd (Meridian Energy) is a state-owned energy utility that generates, trades and retails electricity. It utilizes renewable energy sources such as wind and water for generation of electricity. It also procures electricity from the wholesale electricity market. The company sup …
  • GrowMax Resources Corp (BOE):企業の財務・戦略的SWOT分析
    Summary GrowMax Resources Corp (GrowMax), formerly Americas Petrogas Inc is an oil and gas company that offers exploration and development of conventional and unconventional oil and gas properties in Argentina. The company explores and develops phosphate and potassium-rich brine resources in northwe …
  • Midatech Pharma US Inc:医療機器:M&Aディール及び事業提携情報
    Summary Midatech Pharma US Inc (Midatech Pharma), formerly DARA BioSciences, Inc., is a pharmaceutical company which focuses on the development and commercialization of cancer treatment and supportive care products. It is a subsidiary of Midatech Pharma Plc. The company’s product portfolio includes …
  • Techno – Agricultural Supplying (TSC):企業の財務・戦略的SWOT分析
    Techno - Agricultural Supplying (TSC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Avery Dennison Corporation (AVY):企業の財務・戦略的SWOT分析
    Avery Dennison Corporation (AVY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • InterContinental Hotels Group Plc:企業のM&A・事業提携・投資動向
    InterContinental Hotels Group Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's InterContinental Hotels Group Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mer …
  • Telefonica, S.A.:企業の戦略・SWOT・財務情報
    Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report Summary Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Assembly Biosciences Inc (ASMB):製薬・医療:M&Aディール及び事業提携情報
    Summary Assembly Biosciences Inc (Assembly), formerly Ventrus Biosciences Inc is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of infectious diseases such as microbiotic therapies for Clostridium diffic …
  • Sky plc:企業のM&A・事業提携・投資動向
    Sky plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Sky plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital ra …
  • iMedX Inc-医療機器分野:企業M&A・提携分析
    Summary iMedX Inc (iMedX) is a provider of medical document management and health information solutions. The company offers transcription services and coding services. It provides iMedX Express web based platforms and iMedX Mobile with DocAssist applications. iMedX’s transcription services comprise …
  • TClarke PLC (CTO):企業の財務・戦略的SWOT分析
    TClarke PLC (CTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Litgrid AB (LGD1L):企業の財務・戦略的SWOT分析
    Litgrid AB (LGD1L) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Boursorama Sa:企業の戦略・SWOT・財務分析
    Boursorama Sa - Strategy, SWOT and Corporate Finance Report Summary Boursorama Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Polimex-Mostostal SA (PXM):企業の財務・戦略的SWOT分析
    Polimex-Mostostal SA (PXM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Barrick Gold Corp:企業の戦略・SWOT・財務情報
    Barrick Gold Corp - Strategy, SWOT and Corporate Finance Report Summary Barrick Gold Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Acasti Pharma Inc (ACST)-製薬・医療分野:企業M&A・提携分析
    Summary Acasti Pharma Inc (Acasti), a subsidiary of Neptune Technologies & Bioressources Inc is a biopharmaceutical company that offers research, development and commercialization of prescription drugs. The company offers products such as Onemia and CaPre. Its CaPre is developed for the prevention a …
  • MolMed SpA (MLM):企業の財務・戦略的SWOT分析
    Summary MolMed SpA (Molmed) is a biotechnology company which offers research, development, manufacturing and clinical validation of novel anticancer therapies. Its pipeline antitumour products include Zalmoxis (TK), a cell based therapy enabling bone marrow transplants donors for the treatment of hi …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆